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Summary: The purpose of this study was to determine whether patients 
who become carriers of methicillin-resistant Staphylococcus CZUY~ZLS (MRSA) 
during their stay in hospital, remain colonized after discharge. Thirty-six 
patients colonized with MRSA during one of three outbreaks at Utrecht 
University Hospital (1986689) were screened 2 or 3 years after they had 
become carriers. Patients were also interviewed to determine factors contri- 
buting to persistent carriage, such as antibiotics, re-admissions to the 
hospital, presence of skin lesions and chronic diseases. At the same time 
transmission of MRSA to family members was determined. The epidemic 
MRSA strain was still found in three patients (8%). One was a cystic fibrosis 
patient who had had frequent re-admissions to the hospital and had received 
several courses of antibiotic treatment. Both of the other patients had skin 
lesions: a fistula and a colostomy respectively. None of the 44 family members 
of the patients was colonized or infected with MRSA. We conclude that long- 
term MRSA carriage occurs with low frequency and is comparable to 
persistent carriage of methicillin-sensitive Staphylococcus aureus (MSSA). 
Transmission of MRSA to healthy individuals in an antibiotic-free environ- 
ment is a rare event. 
Keywords: Methicillin-resistant Staphylococcus ~ZLY~US (MRSA); persistent 
MRSA carrier; transmission to family members. 
Introduction 
The incidence of infections due to methicillin-resistant Staphylococcus 
aweus (MRSA) strains in American and European hospitals has increased 
over the past 20 years. 1,2 Also resistance of MRSA to newer antibiotics, 
such as quinolones, has been r;ported with increasing frequency.3 
Control strategies are advised in order to prevent further spread of 
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MRSA in hospitals and nursing homes4,’ While much is known about the 
behaviour of MRSA in these institutions during outbreaks, follow-up data 
on the carriage of MRSA in patients who have been discharged from the 
hospital are not available. Also, little is known about the spread of MRSA 
strains in the community, particularly to relatives of MRSA-carrying 
patients. At Utrecht University Hospital three outbreaks of infection due to 
the same MRSA strain took place between 1986 and 1989, during which 62 
patients became colonized or infected. 6 Every time one of these patients is 
re-admitted, standard isolation procedures are followed to prevent 
re-introduction of MRSA into the hospital. 
The aim of this study was to determine whether patients remain carriers 
of MRSA following their discharge. Long-term carriage was defined as 
carriage for more than 1 year. Therefore, in the period between December 
1990 and March 1991 we determined the carriage of MRSA among the 
patients who had been colonized or infected with MRSA during any of the 
three MRSA outbreaks. Cultures for bacteriological investigation were 
taken from these patients at home. To determine possible spread within 
families, family members were screened for MRSA as well during the same 
visit. 
Patients and methods 
Patients 
A protocol with procedures was approved by the Medical Ethics Committee 
of Utrecht University Hospital. All patients who had become infected 
and/or colonized with MRSA during one of the three MRSA outbreaks in 
1986, 1987 and 1988/89, were traced through municipal offices. Their 
medical records were reviewed and the following variables were abstracted: 
reason for admission to the hospital, treatment of infections with MRSA 
and treatment of MRSA carriage. During outbreaks patients with MRSA 
infections had been treated with intravenous vancomycin. The treatment of 
carriage had consisted of nasal application of neomycin-bacitracin cream. If 
this treatment had failed a second course with this nasal cream (first 
outbreak) or with mupirocin (second and third outbreaks) had been 
prescribed. In addition, a disinfectant soap containing either 
hexachlorophane, or chlorhexidine, had been used for 7 days. Perineal 
carriers had been treated with 125 mg vancomycin po 6-hourly in 1987 and 
1988189. 
A letter was sent to the patients in which the aim of the study and the 
procedures to follow were explained. The family members, i.e. those living 
in the same house, received a separate letter. One member of the study team 
(H.M.E.F.) made an appointment with the patients and their relatives for 
the interviews and for taking samples for culture. 
Interviews 
Interviews focused on four factors that might have played a role in 
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persistent carriage of MRSA: ( ) a antibiotic courses of at least 5 days 
duration or intravenously administered antibiotics which were prescribed 
since discharge from the hospital; (b) any admission to a hospital or nursing 
home since discharge; (c) the presence of skin lesions or skin diseases, either 
persisting open wounds and stomata or chronic skin diseases such as eczema 
or psoriasis; (d) the present health status of the patients as compared to their 
‘original’ health status upon admission to the Utrecht University Hospital: 
(i) total recovery from this disease or (ii) still suffering from the original 
disease and/or its complications. 
Bacteriological investigations 
Cotton-tipped swabs were used to obtain samples for culturing. Cultures 
were taken of the anterior nares, throat and perineum. If present, skin 
lesions were also cultured. Family-members were screened for MRSA by 
nasal swabs only. Specimens were transported to the laboratory within 6 h 
after sampling. Direct plating was performed on 5% sheep blood agar, 
mannitol salt agar and Mueller-Hinton agar supplemented with 10 pg ml-’ 
methicillin. The swabs were then placed in a staphylococcal enrichment 
broth supplemented with methicillin (10 lrg ml-‘) to increase sensitivity.7 
Giolitti-Cantoni broth was used for this purpose.’ In this broth potassium 
tellurite is used as a colour indicator for the presence of S. aweus. 
Methicillin was added to a concentration of 10 1.18 ml-r. Preliminary 
experiments indicated that less than 10 MRSA colony-forming units (cfu) 
ml-’ were detectable in this broth. The agar plates and enrichment broth 
were incubated for 48 h at 35°C. Colonies suspected to be S. azweus were 
tested for catalase and tube coagulase. After 24 or 48 h the broth was 
subcultured on blood agar if change of colour had taken place. All S. aweus 
isolates were phage-typed. The international set of phages was used at 
loo-fold RTD as well as at RTD. Additional phage typing was performed 
with a set of Dutch phages’ and a set of experimental phages specific for 
typing MRSA-strains. Resistance to co-amoxiclav and methicillin was 
tested by determination of minimal inhibitory concentration (MIC) values 
by agar dilution according to the standards of the National Committee of 
Clinical Laboratory Standards. Other antibiotics were tested according to 
the recommendations of the Dutch Working Party on susceptibility 
testing.” 
Statistical analysis 
Fisher’s exact test was used for statistical analysis. 
Results 
Thirty-six patients were still alive at the time of this study; they all agreed to 
participate (Table I). These patients were surveyed between 18 months and 
3 years after their discharge. Forty-four family members took part, only two 
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Table I. Patients enrolled in the MRSA-study 
Involved in Available for Treated for Treated for Not treated 
outbreak study *infection and carriage only 
tcarriage 
11 5 3 0 2 
19 11 4 4 3 
32 20 8 6 6 
62 36 15 10 11 
*Infections with MRSA were treated with vancomycin intravenously. 
TCarriage of MRSA was treated with nasal creams (neomycin/bacitracin and/or mupirocin), disinfectant 
soap (hexachlorophane or chlorhexidine) and oral vancomycin (in case of perineal carriage). 
family members refused to do so. Six patients lived in Utrecht. The other 30 
families lived outside Utrecht up to distances of 1.50 miles away. 
Long- term MRSA-carriers 
Three patients were still carriers of MRSA. In each case, phage typing and 
antibiogram confirmed the MRSA strain to be identical to the epidemic 
MRSA strain of the three hospital outbreaks. This strain was not typable 
with the international set of phages, but could be typed with the 
experimental set of MRSA phages as l/16/23/24/25/26. The antibiogram 
showed resistance to methicillin (MIC > 64 mg l-l), co-amoxiclav (MIC 
> 16 mg l-l), gentamicin (MIC > 16 mg l-l), tetracycline (MIC > 4 mg l-l), 
erythromycin (MIC > 4 mg l-l), clindamycin (MIC > 4 mg l-l), rifampicin 
(MIC > 1 mg l-l), intermediate resistance to ciprofloxacin (MIC=4 mg 1-l) 
and amikacin (MIC=4 mg 1-l). It was sensitive to neomycin (MIC 
< 1 mg l-l), fusidic acid (MIC < 1 mg l-l), chloramphenicol (MIC ~4 mg I-‘), 
co-trimoxazole (MIC < 0.12 mg l-l), vancomycin (MIC < 2 mg 1-l) and 
mupirocin (MIC < 0.12 mg I-‘). The medical histories of the persistent 
MRSA carriers and the results of culture of their relatives were as follows. 
Patient no. 1: 18-year-old male. This patient was first admitted to Utrecht 
University Hospital in 1987 because of acute oesophageal bleeding. After 
surgery he was nursed in the Intensive Care Unit at the time of the second 
MRSA outbreak. He developed abdominal abscesses with MRSA. Cystic 
fibrosis was diagnosed as the underlying cause of cirrhosis and oesophageal 
bleeding. His hospital stay lasted 4 months, during which 
neomycin-bacitracin and mupirocin nasal creams, hexachlorophane 
disinfectant soap and oral vancomycin were given for eradication of MRSA. 
MRSA carriage, however, persisted. Since discharge in October 1987 he 
was re-admitted several times, during which, treatment with intravenous 
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antibiotics was necessary. Each time standard isolation procedures were 
followed and repeated courses of nasal cream (neomycin-bacitracin and 
mupirocin) were prescribed, together with chlorhexidine disinfectant soap 
and oral vancomycin. Despite this treatment, MRSA has been cultured 
from various body sites such as sputum, sinus secretion and abdominal pus. 
At the time of the follow-up for this study, MRSA was cultured from his 
anterior nares, throat and sputum, 27 months after his first discharge. His 
mother and brother were negative for MRSA while his father carried a 
methicillin-sensitive S. aUreUS (MSSA) strain. 
Patient no. 2: 56-year-old male. This patient was admitted to our hospital 
in August 1988 with rupture of an abdominal aneurysm. He had a 
prolonged postoperative course with abdominal complications. He 
developed an intravenous-catheter-related bloodstream infection with 
MRSA during the third MRSA outbreak and was the index patient. MRSA 
eradication was attempted with nasal creams (neomycin-bacitracin and 
mupirocin), chlorhexidine soap and oral vancomycin. MRSA was cultured 
from a decubitus wound up to 2 weeks before he left our hospital. Since his 
discharge in March 1989 he has not been re-admitted to a hospital. At the 
time of this follow-up, an abdominal slime fistula was present, which was 
still productive. Direct plating of all cultures was negative, but the MRSA 
strain was isolated after 48 h from the broth culture of his throat specimen. 
The perineal swab yielded a strain of MSSA which was typable with the 
international set of phages. MRSA was not isolated from his wife or three 
children. One daughter carried an MSSA strain, different from the MSSA 
strain of her father. Hence, patient no. 2 has been a carrier of the epidemic 
MRSA strain for over 2 years. 
Patient no. 3: 68-year-old male. His medical history included a colostomy 
following a rectal amputation (in 1983) and hemiparesis due to a 
cerebrovascular accident in 1987. He underwent cardiovascular surgery for 
aortic valve replacement in January 1989. Postoperatively, he developed a 
sternal wound infection with MRSA. MRSA was also cultured from his 
nose and colostomy. Mupirocin nasal cream, chlorhexidine soap and oral 
vancomycin had been prescribed for 7 days. All cultures had been negative 
for MRSA during the last 2 days of his stay in hospital. 
His nasal swab grew MRSA after 24 h on agar plates and in broth. A swab 
taken from the colostomy and a throat swab were both negative for MRSA. 
At the time of this study he has been a persistent MRSA carrier for 2 years 
after his discharge from hospital. His wife did not participate in the study. 
Families 
In the remaining 33 patients MRSA was not isolated. In this group 37 
family members were screened. MRSA was not cultured from any. All 
family members, including the seven family members of the three persistent 
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MRSA carriers, were individuals without a recent or long-term medical 
history. 
In 17 of the 36 families a MSSA strain was isolated from the patient 
and/or one or more family members. Two such families were families with a 
persistent MRSA carrier (nos 1 and 2). In three families the patient was 
colonized with MSSA, and in eight families only one or more members 
were MSSA carriers. In four families both the patient and family members 
were found to carry a MSSA strain. Apart from the family of MRSA carrier 
no. 2 in which two different MSSA strains were found, the same MSSA 
strain within one family was present as was shown by phage-typing and 
antibiogram. All MSSA strains were sensitive to the antibiotics tested and 
to mupirocin. 
Interviews 
The results of the interviews are summarized in Table II for the 
MRSA-positive (N = 3) and MRSA-negative (N = 3 3) patients. There were 
no statistically significant differences between the groups. 
Discussion 
Methicillin-resistant S. aureix (MRSA) is a well-known and well-studied 
cause of outbreaks of hospital infection. The rate of MRSA carriage among 
patients and staff during epidemics and the attack-rate of MRSA have been 
delineated.4,” To terminate these outbreaks the necessity for stringent 
control measures has been stressed. 
Carriage of MRSA is prolonged in patients in long-term facilities, where 
antibiotics are frequently prescribed to those with chronic diseases.‘2”3 The 
natural history of MRSA carriage in patients that have been infected or 
colonized with MRSA during a hospital outbreak and return home 
afterwards, has not been studied to date. The carriage of S. aUreUS and later 
of penicillin-resistant S. aureu~ has been the subject of considerable 
research in the 1950--60~.‘~~‘~ Acquisition of penicillin-resistant strains was 
Table II. Risk factors for persistent carriage of MRSA 
Patients MRSA-positive MRSA-negative 
(N=3) (N= 33) 
Antibiotics since discharge (a) 1 18 
Re-admissions to hospital (b) 1 9 
Skin lesions and diseases (c) 2 12 
Persistence of underlying disease (d) 3 10 
P-values were calculated with Fisher’s exact test (a: P= 0.59; b: P= 1 ,OO; c: P= 0.55; d: P= 0.22). 
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shown to be enhanced by the administration of antibiotics during the stay of 
the patient in hospital. I6 The acquisition of penicillin-sensitive S. ~UY~US 
was more readily followed by a persistent carrier state than acquisition of a 
penicillin-resistant S. UUY~US in a study among recruits of the Royal Air 
Force.” Thompson showed that carriage of penicillin-resistant S. ~UY~US 
persisted longer in nurses than carriage of multiply resistant (penicillin, 
sulphonamide, streptomycin, chloramphenicol, tetracycline resistant) 
strains.17 In 1964, Noble et al. performed a 6-month follow-up study in 
healthy individuals to determine the rate of S. u.UYeUS carriage. From the 
data of t_his study we recalculated that the rate of persistent MSSA carriage 
in a normal population is 13%.i8 
We have performed a study among patients who have been infected or 
became colonized with the same MRSA strain during one of three 
outbreaks (1986-89) in our hospital. Three of 36 patients (8%) were 
persistent MRSA carriers. This rate does not differ significantly from the 
persistent carrier rate for MSSA found by Noble et al.” 
Interviews were conducted with the patients in an attempt to identify 
factors which could contribute to the continuing MRSA carriage. 
Antibiotic courses and re-admissions to hospital have been considered to be 
such factors. l6 In a normal pop ulation carriers of penicillin-resistant S. 
aUYeUS were found to have more skin diseases than carriers of 
penicillin-sensitive S. u.UYeUS strains.18 Moreover, chronic debilitating 
diseases predispose to a high rate of carriage of multiresistant 
microorganisms. 12,19 One of the persistent MRSA carriers was a cystic 
fibrosis patient. Cystic fibrosis patients are known to harbour multiresistant 
microorganisms, e.g. Pseudomonas, and are often not able to clear these 
bacteria.20 During re-admissions to our hospital after his discharge in 1987, 
this patient has had repeated courses of intravenous antibiotics. The other 
two persistent MRSA carriers were both involved in the third MRSA 
outbreak (1988/89). They have not been re-admitted nor have they received 
antibiotics. Common factors in these two patients were skin lesions and 
faecal incontinence. In nursing-home patients faecal incontinence is 
considered as a contributing factor to persistent carriage of multiresistant 
microorganisms. l2 However, the distribution of risk factors between MRSA 
carriers and non-carriers was not significantly different. 
To reduce the risk of false-negative cultures a selective enrichment broth 
for all culture specimens was included. For epidemiological surveillance the 
use of such a broth is advised.7T21,22 In one persistent MRSA carrier the 
MRSA strain was only found in the broth culture of the throat swab. The 
throat is a known reservoir for recolonization of the anterior nares.23 
The risk of spread of MRSA to the community is unknown, but is 
suggested to be 10w.~~ In most MRSA outbreaks only 2-S% of hospital staff 
are colonized.25 This is much lower than the rates reported in outbreaks 
with MSSA in the 1950~.~~ Transmission of an epidemic MRSA strain to 
family members was not revealed in this study. Except for one family 
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(persistent MRSA carrier no. 2, who also harboured a MSSA strain), the 
same MSSA strain was always detected within one family. 
We conclude that long-term carriage of MRSA occurs at a low frequency 
and is comparable to persistent MSSA carriage. Transmission of MRSA to 
healthy individuals in an antibiotic-free environment is a rare event. 
Re-introduction of MRSA into a hospital is likely to occur with the 
re-admission of a colonized patient or of his contacts in the community.27’28 
At Utrecht University Hospital we have tagged the medical records of our 
MRSA-carrying patients and we adhere to standard isolation and screening 
procedures when they are re-admitted. We also follow these rules for 
patients transferred to our hospital after a stay in a hospital abroad. So far, 
we have had no reason to apply these rules to relatives of MRSA patients as 
well. 
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